MRI safety and devices: An update and expert consensus by Jabehdar Maralani, Pejman et al.
Zaharchuk Greg (Orcid ID: 0000-0001-5781-8848) 
Jabehdar Maralani Pejman (Orcid ID: 0000-0001-9975-4379) 
 
1 
Title: MRI safety and devices: An update and expert consensus 
 
Author Names and Degrees: 
Pejman Jabehdar Maralani (MD) 1 
Nicola Schieda (MD) 2 
Elizabeth Hecht (MD) 3 
Harold Litt (MD, PhD) 4 
Nicole Hindman (MD) 5 
Chris Heyn (MD, PhD) 1 
Matthew S Davenport (MD) 6  
Greg Zaharchuk (MD, PhD) 7 
Christopher Hess (MD, PhD) 8 
Jeffrey Weinreb (MD) 9 
 
Author Affiliations: 
This article is protected by copyright. All rights reserved.
This is the author manuscript accepted for publication and has undergone full peer review but
has not been through the copyediting, typesetting, pagination and proofreading process, which




1Department of Medical Imaging, University of Toronto, Toronto, Canada 
2Department of Radiology, University of Ottawa, Ottawa, Canada 
3Department of Radiology, Columbia University, New York, USA 
4Department of Radiology, University of Pennsylvania, Pennsylvania, USA  
5Department of Radiology, New York University, New York, USA 
6Department of Radiology, University of Michigan, USA 
7Department of Radiology, Stanford University, Stanford, USA 
8Department of Radiology and Biomedical Imaging, University of California, San Francisco, 
California, USA 




Corresponding Author Info: 
Pejman Jabehdar Maralani, 2075 Bayview Avenue – Room AG270c, T: 416-480-6100, x3546; 
F: 416-480-5855; E-Mail: pejman.maralani@utoronto.ca  





Deanna Reynolds MRT (R)(MR) 
Shelley Landers MRT (R)(MR) 
Stacy Vilu MRT (R) MR  
Susan Crisp R.T (NM) (MR) 
Aimee KM Chan MSc 
Alain Berthiaume R.T. (R) (MR) 
Joshua Morel R.T. (R) (MR) (MRSC™) 
 
Grant Support: N/A 
 
Running Title: MRI safety and devices 
 
 
This article is protected by copyright. All rights reserved.
4 
 
TITLE: MRI safety and devices: An update and expert consensus 
ABSTRACT:  
The use of magnetic resonance imaging (MRI) is increasing globally, and MRI safety issues 
regarding medical devices, which are constantly being developed or upgraded, represent an 
ongoing challenge for MRI personnel. To assist the MRI community, a panel of 10 radiologists 
with expertise in MRI safety from 9 high-volume academic centers formed, with the objective of 
providing clarity on some of the MRI safety issues for the 10 most frequently questioned 
devices. 10 device categories were identified. The panel reviewed the literature, including key 
MRI safety issues regarding screening and adverse event reports, in addition to the 
manufacturer’s Instructions For Use. Using a Delphi-inspired method, 36 practical 
recommendations were generated with 100% consensus that can aid the clinical MRI 
community.  
Keywords: MRI, safety, medical devices 
  




The use of magnetic resonance imaging (MRI) is increasing globally (1). In addition, medical 
devices are continually being developed or upgraded, presenting a unique challenge to healthcare 
professionals who need to ensure compatibility prior to scanning to prevent or reduce potential 
adverse events (AEs).  
Briefly, from a MRI safety perspective the main concerns stem from: 1) the static magnetic field, 
which can contribute to projectile effects; 2) the gradient field, which can cause current 
induction; and 3) the radiofrequency (RF) field, which can result in device heating. All three 
contribute to Specific Absorption Rate (SAR). Further details are covered by Shellock and Crues 
(2). The primary safety concerns in patients with biomedical implants or devices are related to 
the presence of ferromagnetic materials such as iron or stainless steel. These can potentially 
move, induce electrical currents, or undergo RF-induced heating (3). Non-ferromagnetic 
materials such as tantalum, titanium, nitinol, copper, MP35N, or plastic do not pose a risk for 
movement when exposed to a magnetic field, however non-ferromagnetic metallic objects share 
the potential to undergo RF-induced heating and current induction, particularly when they are 
elongated or form a loop (4).  
Concerns regarding compatibility of MRI and implants led to standardization of medical device 
testing, labelling, and terminology by ASTM International (including but not limited to F2503, 
F2052, F2189), while implantable portions of “active”— those that utilize any source of power 
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other than those generated within the human body or gravity—implant standards fall under the 
International Organization for Standardization, Technical Standard (ISO/TS; latest guidelines, 
ISO/TS 10974:2018). Several guidelines for MRI safety practices have also been issued by 
radiological societies, e.g., American College of Radiology (ACR; (5)), Canadian Association of 
Radiologists (6), and European Union (7). Additional publications (3,8) and online resources, 
such as www.MRIsafety.com, are also available that detail device and MRI compatibility. 
Despite the abundance of resources situations outside of those defined by the Instructions For 
Use (IFUs) still arise, resulting in uncertainty on how to assess safety for an MRI scan and 
leading to refusal of MRI, which can impact patient care or treatment decisions. To address some 
of the more common scenarios that occur, a panel of radiologists reviewed the literature on the 
MRI safety of 10 frequently questioned categories of devices and used a Delphi-inspired method 
to generate recommendations on screening and safety procedures. The purpose of this work is to 
present an updated review outlining the main safety, screening and scanning concerns, as well as 
the AE reports for each device category, and to provide the MRI community with practical 
recommendations. These recommendations are also useful in risk-benefit assessment when 
patients present in scenarios not detailed in the IFUs.  
METHODS 
A group of 10 radiologists, varying in their subspecialty and with 7-35 years of experience, was 
formed from 9 high-volume academic institutions. A modified Delphi approach was chosen as it 
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facilitates group judgements and allowed for the formation of a multi-institutional group of 
experts. The inherent anonymity ensured all member opinions held equal weighting during the 
formation of the recommendations. Three Delphi rounds were held with the stop criterion being 
achievement of 100% consensus on >95% of questions.  
An open discussion was first held to determine the 10 medical device categories that would be 
covered. Based on their subspecialty, one to three radiologists were then assigned to a category 
and instructed to review and summarize the literature. Product IFUs were also reviewed, as these 
undergo rigorous scrutiny by the regulating bodies of their respective jurisdiction prior to 
approval and marketing. For example, in the United States (US), the Food and Drug 
Administration (FDA) oversees this. Peer-reviewed publications were also included, despite the 
methodology not necessarily adhering to the standards set by the ASTM International or ISO/TS 
publications, as they held valuable information regarding the safety concerns of several device 
categories. 
Authors then generated up to 8 statements that could be evaluated as recommendations during 
the Delphi rounds. To ensure consistency amongst the recommendations, authors were instructed 
to use MRI safety risk category terminology (Table 1) based on those used by US FDA.  
In each Delphi round, authors were sent the consolidated sections to review. An electronic 
questionnaire with the recommendations was subsequently sent out to all authors, with answers 
limited to either “Agree” or “Disagree.” A third-party facilitator collected the results to ensure 
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anonymity, and also reached out to authors for their rationale when their answer differed from 
the majority. This information was fed back to all authors and used to provide structure to the 
teleconference which occurred in the subsequent week and covered topics where full consensus 
was not reached. Afterwards, the authors could amend their sections and/or provide improved 
recommendations. This process was repeated for all statements where full consensus was not 
reached until the stop criterion was met, after which no teleconference was held.  
RESULTS 
10 categories were chosen for review: 1) epidural and peripheral nerve catheters; 2) spinal cord 
and peripheral nerve stimulators; 3) cochlear implants; 4) scleral buckles and retinal tacks; 5) 
coronary and carotid stents; 6) legacy pacemakers and defibrillators; 7) retained epicardial pacer 
wires and abandoned pacemaker leads; 8) endoscopic hemostatic clips and video capsule 
endoscopic recording devices; 9) intrauterine and fallopian tube closure devices; and 10) bullets, 
shrapnel, and foreign metallic objects.  
A total of 3 Delphi rounds were held, with 100% response rate for each (Figure 1). In the first 
Delphi round, 42 recommendations were sent to authors. During the teleconference, three 
recommendations were removed due to redundancy, and two due to lack of specificity; 100% 
consensus was achieved on 48.6% (18/37) recommendations. During the second Delphi round, 
84.2% (16/19) of the remaining 19 recommendations achieved 100% consensus. On the last 
Delphi round, 100% (3/3) consensus was achieved. One recommendation was removed during 
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the review process of this manuscript, therefore a total of 36 recommendations with 100% 
consensus is presented (Table 2).  
As most literature regarding clinical MRI safety are limited to 1.5T and 3T, recommendations 
provided here only apply at these field strengths unless otherwise stated. Although FDA 
terminology for MRI risk categories (Table 1) were used, it should be noted that 
recommendations are literature-supported and not jurisdiction-based. Devices with active, 
implanted components should have the device settings applied as per the IFU whenever possible. 
However, specific risks and benefits of an MRI scan should always be assessed on a case-by-
case basis if an implant does not have MRI labeling or if the MRI conditions indicated in the IFU 
cannot be followed.  
DISCUSSION 
Epidural and Peripheral Nerve Catheters (Box 1) 
Epidural and peripheral nerve catheters are placed for continuous delivery of local anesthetics or 
analgesics into the epidural or perineural space for pain relief. They are often placed for 5-7 days 
in the post-operative setting for patient-controlled analgesia, although extended periods are 
common during the palliative care of oncology patients (9). Peripheral nerve catheters are most 
commonly used for orthopedic surgeries in the peri- and post- operative period. 
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Several changes in their material composition and design have occurred over the years (10). 
Many of these catheters contain a metal wire which improves their maneuverability and ease of 
placement. Due to this wire, the specific risks associated with these catheters include potential 
for displacement when placed in a static magnetic field and RF-induced heating. In 2002, 
Shellock (11) reported that an epidural catheter manufactured with 604V stainless steel 
(Arrow®, PA, USA) showed limited deflection and rotation at 3T, but communication with 
Arrow® indicates no catheters are currently manufactured using stainless steel. In the only other 
study found, Owens et al. (12) did not adhere to the strict testing standards published by ASTM 
International, and ISO/TS 10974 was not published at the time. Instead, the methodology 
focused on compliance with the FDA’s RF and SAR guidelines under in vitro settings. They 
demonstrated the StimuCath Peripheral Nerve (Arrow International, PA, USA) and Perifix FX 
Epidural (B. Braun Medical Inc., PA, USA) catheters are MR Unsafe. They also demonstrated 
that the Epifuse Nylon (Smith/Portex, NH, USA), Flex-Tip Plus, and MultiPort Flex-Tip Plus 
(Arrow®) epidural catheters, and the Contiplex Polyamide (B. Braun Medical Inc.) peripheral 
nerve catheter, do not have RF-heating related issues and can be left in place at 1.5T. 
Furthermore, temperature increases by the Contiplex Polayamide (B. Braun Medical Inc.) and 
Epifuse Nylon (Smith/Portex) were limited, with ≤3°C increases when scanned at 3T, and may 
also be safe to leave in place. This study did not address MR-related movement of these 
catheters.  
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To date there have been no reports of harm caused by MRI in patients with epidural or peripheral 
nerve catheters. One case report described a patient with retained epidural nerve catheter tip who 
did not have any MR-related AEs when scanned at 1.5T (13). Another also reported no AEs, but 
with unknown catheter model and magnetic field strength (14). A study that included patients 
scanned with epidural or peripheral nerve catheters did not report any AEs as a result of the scan, 
although MRI safety was not the focus of the study (15). Due to the limited number of studies 
assessing MRI safety with these devices, screening is recommended and when present the 
manufacturer guidelines should be followed for the specific model.  
Spinal Cord Stimulators with implanted pulse generators and Peripheral Nerve Stimulators 
(Box 2) 
Nerve stimulators are used for a diverse number of indications which are constantly expanding. 
This section focuses on spinal cord and peripheral nerve stimulation systems, used for pain 
control; vagus nerve stimulation systems, used for seizure control and drug-resistant depression; 
and sacral nerve stimulation systems, used for bowel and bladder control. Despite indication 
differences, most nerve stimulators utilize similar designs and are composed of: an implantable 
or external pulse generator with battery; lead wires, with a variable number of electrodes; and an 
external console to program and adjust settings (16). In general, the location of the electrode 
dictates type: spinal cord electrodes are implanted within the epidural space; peripheral nerve 
stimulation-specific leads utilize wire- or paddle- type electrodes within the extremities—note, 
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these leads were introduced in mid-2000s as prior to that, spinal cord leads were used; vagus 
nerve electrodes are placed next to the vagus nerve in the neck; and sacral nerve leads are placed 
along the sacral plexus, usually anterior to the S3 neural foramen. Except for vagus nerve 
stimulation systems, patients initially have a trial system implanted for a few weeks prior to 
implantation of a permanent system.  
The primary MRI safety concerns for these systems involve heating (16); possible alterations to 
device settings, necessitating reprogramming or replacement surgery; unintentional stimulation; 
and torque or displacement of the implanted pulse generator.  
Due to the diversity of possible configurations and ongoing developments, it is important to 
always check manufacturer specifications to obtain the latest device and safety information prior 
to scanning. According to all current manufacturer guidelines, MRI should usually be avoided in 
patients with abandoned devices or components; or broken, non-functional, or dislocated spinal 
cord, vagus nerve, or sacral nerve stimulation components. No literature reports were found 
where MRI safety was assessed with abandoned devices or components. Devices with external or 
removable pulse generators have less restrictions compared to traditional neuromodulation 
systems (17). All current manufacturer guidelines state that the trial systems and external 
components of all permanent systems are MR Unsafe.  
Spinal cord stimulation systems with implanted pulse generators: 
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Historically presence of a spinal cord stimulation system with an implanted pulse generator has 
been considered a contraindication for MRI. Technological improvements have led to the 
development of systems that are MR Conditional following specific parameters, as outlined in 
manufacturer IFUs. When scanning patients with these devices at 1.5T, the most commonly 
reported side effect during MRI is transient warmth at the implanted pulse generator or electrode, 
that was insufficient to cause burns (18,19). In one report, two patients could not have telemetry 
performed after 1.5T MRI, however this was attributed to total battery exhaustion rather than an 
MRI-induced effect (19). No serious AEs have been reported. No reports were found on patients 
undergoing MRI with newer systems that utilize high-frequency stimulation such as Senza 
(Nevro Corporation, CA, USA). If the epidural leads are displaced into the subdural or 
intrathecal space, MRI could result in spinal cord injury or stimulation (Table 2). There is on-
going research for subdural spinal electrodes (NCT03380104). 
Peripheral nerve stimulation systems: 
When spinal cord stimulation system electrodes are used off-label as peripheral nerve stimulation 
system leads, it is important to know the electrode model and consult the IFU prior to MRI. 
Peripheral nerve stimulators with implanted pulse generators should generally undergo the same 
considerations as those outlined for spinal cord stimulation systems with implanted pulse 
generators; therefore, this section will only encompass dedicated peripheral nerve stimulation 
systems with external pulse generators.  
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SPR Therapeutics (Cleveland, OH, USA) has approved leads that are MR Conditional at 1.5T, 
though testing has shown that 3T scans are feasible (20). Similarly, StimWave Technologies Inc. 
(Pompano Beach, FL, USA) have peripheral nerve stimulation system leads that are MR 
conditional at 1.5T, while Bioness Inc. (Valencia, CA, USA) has a lead that is MR Conditional at 
1.5T and 3T; these are currently the only companies with FDA approval for their systems. One 
study examined the MRI safety of retained fragments of SPR Therapeutics peripheral nerve 
stimulator leads and found that 1.5T scans can be safely performed (20), though no studies on the 
retained leads from other manufacturers were found.  
In Europe, BlueWind Medical (Herzliya, Israel) have approved leads that are MR Conditional at 
1.5T and 3T.  
Implantable vagus nerve stimulation systems: 
The existing implantable vagus nerve stimulation systems are from LivaNova (London, England) 
and Cyberonics (now part of LivaNova). Both are MR Conditional at 1.5T and 3T for brain and 
extremities MRI. Depending on the stimulator, the manufacturer states the scan isocenter should 
exclude C7-T8 or C7-L3. In vitro tests support this exclusion, as the leads may excessively heat 
(21). No serious AEs have been reported when scanning under these conditions (22,23).  
Implantable sacral nerve stimulation systems: 
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Currently, InterStim from Medtronic Inc. (Fridley, MN, USA) is the only FDA-approved system 
and is MR Conditional for brain imaging at 1.5T only, with no serious AEs reported. Although 
non-brain MRs are contraindicated per manufacturer’s guidelines, it is feasible for patients to 
undergo cervicothoracic (24) and lumbrosacral spine MRI (25) under controlled conditions. 
Axionics Modulation (Irvine, CA, USA) has the r-SNM System that is MR Conditional in 
Europe, Australia, and Canada, with varying MRI guidelines for field strength and MRI type 
depending on the geographic region; clinical trials are underway to support its FDA approval 
(NCT02620410, NCT03327948). However, no clinical studies on the MRI safety of the r-SNM 
System could be found.  
Cochlear Implants (Box 3) 
Cochlear implants are used to treat moderate to profound bilateral sensorineural hearing loss and 
single-sided deafness (26). Products from Cochlear® (Sydney, Australia), Advanced Bionics 
(Stafa, Switzerland) and MED-EL (Innsbruck, Austria) have FDA approval. Oticon Medical 
(Vallauris, France) is also a common manufacturer outside the US.  
The system generally consists of an external audio processor and coil transmitter, and a 
subcutaneously implanted receiver coil and stimulator unit. The audio processor can be a 
separate earpiece or integrated with the external coil. The external coil is magnetically mounted 
over the internal magnet within the implanted coil, which stimulates the cochlear nerve within 
the cochlea.  
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The main concerns with MRI are dislocation or movement of the internal magnet causing pain or 
device dysfunction. Less common AEs include demagnetization (27) or reversal of polarity of 
the internal magnet (28).  
All external components of cochlear implant devices are MR Unsafe. The internal components of 
currently marketed devices with the internal magnet in place are MR Conditional at 1.5T as long 
as patients are given some variation of compression wrap and splint for their head. There are 
reported cases of dislocation or tilting of the internal magnet despite the compressive bandage 
(28-30), although patients with Oticon Medical’s Neuro Zti have been scanned at 1.5T with no 
AEs, with or without head wrap (31). Caution should be used when a patient presents with an 
older model, as some that are no longer marketed in North America, including Cochlear’s 
CI22M, Advance Bionics CLARION, and HiResolution 90K series, have different MRI safety 
guidelines.  
The FDA-approved cochlear implants listed above and the Neuro Zti are also MR Conditional at 
3T with the internal magnet removed. MED-EL’s latest device, the SYNCHRONY, is MR 
Conditional at 1.5T and 3T with the magnet in place. No compressive wrap is needed as it has a 
rotatable and diametrically magnetized internal magnet which should prevent its dislocation. No 
AEs have been reported for patients with SYNCHRONY when scanned at 3T (26,30). 
Identification of the implant model is important prior to MR scanning. At 1.5T the internal 
magnet may be left in, or it can be surgically removed if the patient experiences symptoms of 
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dislodgement. Except for MED-EL’s SYNCHRONY, all internal magnets should be removed for 
3T scans. If there is suspicion of magnet dislodgement during or after the MRI, which is almost 
always accompanied by patient discomfort, a Stenvers-view radiograph, in which the head is 
angled 45° from anteroposterior position and X-ray beam is angled 12° cephalocaudally (32), 
should be performed to confirm internal magnet location and position. 
The effect of MRI on cochlear implants when scanning non-brain body parts should be 
considered. If the implant is located near the entrance of the MRI bore, as in abdominal imaging, 
changes in spatial static and time-varying gradient fields are higher than when the brain is near 
the isocenter of the magnet. This will increase the possibility of internal magnet movement (30). 
Cochlear implant magnets cause significant local field inhomogeneities and image artifacts, 
especially within the ipsilateral brain and structures such as internal auditory canal; in these 
cases, the internal magnet may have to be removed to reduce artifacts.  
When the cochlear nerve is non-functional, absent, or destroyed, an auditory brainstem implant 
may be an implanted. The main indication for its use is neurofibromatosis type 2 with bilateral 
vestibular schwannomas, so they are less commonly seen compared to cochlear implants. 
However, like cochlear implants, auditory brainstem implants are also comprised of external and 
implanted components containing an internal coil and magnet; the main difference is that the 
implanted electrode is placed over the surface of brainstem. Nucleus ABI541 and ABI24M 
(Cochlear®) are FDA-approved auditory brainstem implants, are MR Conditional at 1.5T with 
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the magnet in, and MR Conditional at 3T with the magnet removed. Several other companies 
offer their own variation of the auditory brainstem implant (33), including the Digisonic SP ABI 
(Oticon Medical) and the SYNCHRONY ABI system (MED-EL). Given the similarities between 
cochlear and auditory brainstem implants, the same considerations should be taken into account 
when assessing MRI safety.  
Scleral Buckles and Retinal Tacks (Box 4) 
Scleral buckling has been performed since the 1930s. It involves suturing a silicone band onto 
the sclera to treat retinal detachment. Historically, tantalum clips were used to fasten the free-
ends of the band, but currently sutures-only are preferred (34) No reports on the use of metallic 
non-tantalum clips for scleral buckling were found in the literature. No reports of AEs have been 
reported in patients scanned with tantalum clips, and testing as shown they do not exhibit any 
ferromagnetism at 1.5T (35). Given the lack of risks associated with tantalum clips, absence of 
evidence for use of any metallic non-tantalum clips, and lack of any reported AEs in patients 
who had undergone scleral buckling, screening for these are not necessary (35). 
Retinal tacks are used to repair retinal detachments and allow immediate fixation of the retina. 
They are approximately 1x3 mm and have a conical configuration with the sharply-pointed end 
inserted into the retina. They can be composed of a wide range of metallic and non-metallic 
materials. Although largely unused since the 1980s, many commonly employed metallic retinal 
tacks are MR Conditional at 1.5T, with one exception being Western European-type retinal tacks 
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manufactured from martensitic stainless steel (36,37). This retinal tack has have the potential to 
become completely dislodged when placed in the magnetic field of 1.5T scanners, although this 
movement was not sufficient to cause retinal tear or intraocular damage when tested in rabbits 
(36). Due to the limited number of studies, these should be considered MR Unsafe and patients 
should be screened identify MR Unsafe models. No studies examining heating of retinal tacks or 
case studies showing patient harm were identified. Recently, custom-made MR Conditional 
titanium retinal tacks are used to secure components of the retinal prosthesis system Argus II 
(38), and no AEs have been reported in patients undergoing MR at 1.5T or 3T (39).  
Coronary and carotid stents (Box 5) 
Coronary stents were invented in the 1980s to prevent restenosis of arteries after balloon 
angioplasty (40). The initial cardiac stents were permanent bare metals made of alloys such as 
stainless steel and cobalt-chromium. In the 2000s, there was an attempt to improve upon the 
restenosis rate with drug-eluting stents made of the permanent bare metal and a polymer 
overlayer (41). The next generation of cardiac stents includes bioabsorbable stents based on 
magnesium alloys with a poly-L-lactic acid polymer coating (40). The primary MR-related 
concerns are stent displacement and RF-induced heating.  
Most currently marketed and available carotid stents are made of nitinol, 316L stainless steel, or 
a cobalt alloy (42). Less commonly, they are made of alloys including platinum, carbon, gold, 
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MP35N, or tantalum (42,43). Most coronary and carotid stents exhibit non-ferromagnetic or 
weakly ferromagnetic behavior at both 1.5T and 3T (41,44,45).  
The implantation of coronary and/or carotid stents into the vessel wall during the interventional 
procedure immediately anchors the stent, with additional tissue in-growth occurring 6-8 weeks 
later. The forces caused by the magnetic field on the stents have been clinically shown to be 
insufficient at 1.5T or 3T to cause movement. In Hug et al. (2000), ex vivo testing on nineteen 
different coronary arterial stents demonstrated 2/19 as nonferromagnetic and 17/19 as minimally 
ferromagnetic, with no device migration or significant heating (46). Subsequent studies have 
confirmed the safety of both bare metal and drug-eluting cardiac stents immediately after 
implantation (41,47). Therefore, there is no compelling data to support delaying MR imaging for 
6-8 weeks after stent deployment (45,48). 
Regarding RF-induced heating, no clinically significant temperature alterations have been 
observed in stents, with only minimal heating <1°C for a single stent and <2°C for overlapping 
stents (42). No studies have shown an increased risk of stent-related subacute or late thrombosis 
attributable to MRI (48,49). A retrospective review of patients with myocardial infarction who 
underwent MRIs within 2 weeks (median 3 days) of stent placement detected no increased 
incidence of AEs at 30 days or 6-months compared to patients who had not undergone MRI (50).  
Due to their metallic composition, all coronary and carotid stents are MR Conditional (43-45). 
Prior to MRI, the date of stent placement should be obtained and the IFU followed as certain 
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stents have labelling that allow for whole body average SAR of 4 W/kg. Comparatively, patients 
with unknown stent model can be scanned with whole-body-averaged SAR ≤2 W/kg and 
maximum 15 minutes per sequence. All non-ferromagnetic coronary and carotid stents can be 
scanned at 1.5T or 3T immediately after placement. MRI can be safely performed in patients 
with weakly ferromagnetic stents at 1.5T or 3T six weeks after implantation; scanning these 
patients without a 6-week delay can be considered on a case-by-case basis (Table 2).  
Finally, there may be local artifact generated within the lumen of the stent on MRI, limiting 
determination of in-stent patency or thrombosis depending on the stent type (45).  
MR Non-conditional (legacy) Pacemakers and Defibrillators (Box 6)  
Non-conditional or legacy cardiac implantable electronic devices (CIEDs) include pacemakers, 
implantable cardioverter defibrillators (ICDs), and associated leads that have not been 
specifically approved for use in the MRI environment. As many CIEDs have been approved as 
pairs of specific pulse generators and leads, the non-conditional category includes conditional 
generators that have been attached to non-conditional leads (or rarely, vice-versa), or generator-
lead pairs that were not specifically approved for use together. In addition, as devices are only 
approved for use under specific scan conditions, any scan performed outside these conditions 
will render the device non-conditional for that scan. Although many newly implanted 
pacemakers and ICDs are MR Conditional, it is estimated that approximately 6 million patients 
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have legacy devices and 50-75% will have a clinical indication for MRI during the lifetime of the 
device (51). 
There are several potential safety concerns when performing MRI in patients with legacy CIEDs, 
as interactions can occur between the device and various components of the MRI system, 
including the static magnetic, RF, and gradient fields. These interactions can result in changes in 
pacing threshold, inhibition of pacing output, inappropriate pacing, activation of asynchronous 
pacing (magnet mode), inappropriate ICD discharges, decrease in lead impedance, and changes 
in P- and R- wave amplitude (52). A power-on or reset can occur in devices manufactured before 
2002, leading to a change from asynchronous to inhibited pacing (VVI mode), inducing 
bradycardia in pacemaker-dependent patients, causing inappropriate anti-tachycardia pacing or 
shocks to patients with ICDs, or battery depletion (53). Physical effects including device or lead 
movement, heating of the lead electrodes and tissue injury, potential tissue ablation, higher 
battery utilization, and device failure are other potential complications. Additional risks for 
legacy ICDs include increased physical effects related to the larger device relative to pacemaker 
generators and leads, and susceptibility to arrhythmia while tachycardia detection and therapies 
are turned off for MRI (54).  
Despite early reports of fatalities related to MRI in patients with legacy CIEDs (55), many 
groups began to report scanning patients with legacy devices without incident beginning in the 
early 2000s. Recent publications, including two in 2017 comprising nearly 3000 scans (56,57), 
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have resulted in several new specialty society guidelines (8,58). In general, scanning patients 
with legacy devices is supported following screening if: 1) MRI field strength is ≤1.5T using 
Normal Operating Mode; 2) the implanted CIED has no fractured or abandoned intracardiac 
leads (please see “Abandoned Epicardial pacer Wires and Abandoned Leads” regarding scanning 
patients with abandoned leads); and 3) the facility has implemented a checklist process that 
includes the following steps: assessment to identify the presence of a CIED; obtaining informed 
consent; the CIED is interrogated and programmed appropriately based on device and patient 
characteristics; the scan is supervised by an experienced practitioner and advanced 
cardiovascular life support (ACLS)-certified provider, with equipment to monitor vital signs and 
cardiac rhythm; and that the CIED is evaluated prior to discharge to ensure correct function and 
no abnormalities occurred during the scan. Following these guidelines and manufacturer IFUs, 
electrophysiology personnel do not have to be present during the scan but should be on call 
(Table 2). Devices should be checked by electrophysiology personnel after the scan, although 
routine follow-up interrogation is not necessary at 30 days following the scan (Table 2). 
Retained Epicardial Pacer Wires and Abandoned Pacemakers Leads (Box 6) 
Temporary Epicardial Pacing Wires 
Temporary epicardial pacing wires are routinely placed to diagnose and treat arrhythmias in 
the early post-operative period of patients that underwent cardiac surgery (59). These are 
designed for temporary use (59) and are typically removed within a week of surgery; however, 
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sometimes they can be difficult or impossible to remove. In such cases, they are cut at the skin 
surface and retained. Therefore, the retained wires may be of varying lengths.  
Temporary epicardial pacing wires are composed of stainless-steel multithread conductors 
surrounded by an external insulating sheath. Theoretical risks of performing MRI on patients 
with retained temporary epicardial pacing wires include cardiac excitation (60) and thermal 
injury. In a study of 51 subjects undergoing MRI at 1-1.5T, diagnostic imaging was obtained in 
all but two patients who underwent cardiac MRI for investigation of underlying etiology of 
ventricular arrhythmia. In those two patients, their baseline arrhythmia led to poor cardiac gating 
rendering their imaging non-diagnostic (61). Susceptibility effects related to the retained wire did 
not interfere with image quality (61). The authors argued that the currents and voltage required to 
cause arrhythmias are higher than those likely to be generated with the shortened lengths of 
retained temporary epicardial pacing wires (61). However, this study did not address technical 
parameters such as RF deposition and exact anatomic location of scanning (60). Despite low-
level evidence, because of the relatively low risk of complications, expert multidisciplinary 
consensus supports 1.5T and 3T MRI in any body part without routine screening of patients with 
retained temporary epicardial pacing wires (42). In support of that consensus recommendation, 
there have been no reported serious complications from scanning patients with retained 
temporary epicardial pacing wires.  
Temporary Transvenous Pacing Leads 
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Temporary transvenous pacing leads are used for single or dual chamber pacing in a controlled 
environment where continuous monitoring is available. Leads made after 1995 have limited, or 
no, ferromagnetic material so displacement is not a concern (62). However, they have been 
shown to heat up to 20ºC in an ex vivo animal tissue study, but without resultant tissue damage 
(63). The leads are prone to induction of a current even when scanning without the generator. 
Therefore, temporary percutaneously placed transvenous pacemakers are considered MR Unsafe 
and labelled by the vendors as such (42).  
Abandoned Permanent Intracardiac and Abandoned Permanent Epicardial Pacing Leads 
Permanent pacemakers are composed of a generator and intracardiac leads, the latter of which 
pass into and remain embedded in the myocardium. The intracardiac leads may fracture, 
dislodge, or fail to properly function due to a number of factors and require replacement over 
time (64). Some leads are too high risk to remove without causing a complication. In such cases, 
they are disconnected from the pulse generator and typically capped with plastic to reduce risk of 
inadvertent excitation (64). Less commonly encountered are abandoned permanent epicardial 
pacing leads, which are typically placed in pediatric patients (65).  
An ex vivo study demonstrated that abandoned and pacemaker-attached leads show RF-induced 
heating. For clinical lead lengths of 40-60 cm, abandoned leads exhibit greater lead tip heating 
compared with pacemaker-attached leads (64). The coupling of the RF field to the pacemaker 
lead is determined by the amplitude and phase of the electric field along the lead and its length, 
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which results in heating at the lead tip—the portion implanted in myocardium (64). One author 
argues in response to these findings that RF field risk is actually reduced for abandoned leads 
because: a) the abandoned lead acts as an open circuit rather than the short circuit that forms 
when attached to a pulse generator; b) the field coupling mechanism is reduced if the lead is 
fractured or insulation breaks down; c) dislodgement to non-excitable issue or abnormalities in 
pacing and sensing will not destroy excitable tissue but mostly scar tissue; and d) power density 
around the lead tip decreases with the fourth power of the distance or a distance equal to tip 
radius (66). 
Retrospective studies of patients with abandoned leads scanned at 1.5T and SAR ≤1.5W/kg 
reported no AEs (67-69). One study showed no significant change in function in patients who 
underwent MRI and had leads later re-connected to a pulse generator (67). While previous 
guidelines and consensus documents have stated that abandoned leads are an absolute 
contraindication to MRI, these studies suggest that they should be considered MR Conditional at 
1.5T and SAR ≤1.5W/kg. There is no need for additional monitoring beyond standards set for 
imaging patients with permanent leads attached to generators (69). 
Endoscopic Hemostatic Clips and Video Capsule Endoscopic Recording Devices (Box 7 and 8) 
Endoscopic hemostatic clips are used to control gastrointestinal bleeding; secure feeding tubes, 
endoluminal stents and catheters; close mucosal defects, perforations, and anastomotic leaks; and 
mark tumors prior to surgery or radiotherapy (70). MR Unsafe endoscopic hemostatic clips 
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include older generation clips from Olympus America (NY, USA), and the QuickClip, LongClip, 
and TriClip from Cook Endoscopy (NC, USA) (71). Modern endoscopic clips, including the 
QuickClip Pro (Olympus America), Instinct Clip (Cook Endoscopy), Resolution clip (Boston 
Scientific, MA, US), and LIGACLIP (Ethicon Endo-Surgery, OH, USA), are MR Conditional up 
to 3T according to IFUs. Studies evaluating the MRI safety of endoscopic hemostatic clips are 
limited. A single case report published in 2014 (72) describes a patient death from 
cardiopulmonary arrest associated with hematemesis presumed to be due to re-bleeding from a 
laceration below the esophageal sphincter. The laceration was treated with an endoscopic clip 
(Instinct, Cook Endoscopy) and re-bleeding occurred immediately following brain MRI which 
was performed 6 days after endoscopy. The authors attributed the re-bleeding to clip migration 
during the MRI; however, this was not confirmed radiographically or with autopsy. The authors 
did later physically test the endoscopic clip in their MR environment, with no indication of MRI 
field strength, and reported significant movement of the clip in the MRI. The device in question 
is considered MR Conditional up to 3T according to manufacturer specifications. Due to the lack 
of MRI safety data reported in this study, the authors question whether there were alternative 
reasons that resulted in the patient death. No other reports of AEs from retained endoscopic 
hemostatic clips in patients who underwent MRI at any field strength. To our knowledge, there 
are no studies formally evaluating the heating effects of endoscopic hemostatic clips under MRI 
and the potential associated risk to the gastrointestinal tract wall; however, this concern appears 
mainly theoretical. Most endoscopically-placed hemostatic clips detach and are passed in bowel 
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movements within 2 weeks of placement. The Resolution clip is known to have the longest 
attachment, lasting up to 5 weeks in 100% (5/5) of animals studied (70). Cases of endoscopic 
hemostatic clips retained years after placement have been reported but are rare (73,74).  
Although there is a wide variance in screening policies (71), in the case of patients who were 
imaged at a facility which uses non-conditional hemostatic clips or where the type of clip used is 
unknown, these patients should be screened to assess whether endoscopy was performed within 2 
weeks of MRI as patients may be unaware of its placement (Table 2). The presence of a 
hemostatic clip can be confirmed with radiography (75). For patients who are imaged at a facility 
which uses only MR Conditional hemostatic clips, screening patients is of no value (Table 2). It 
should be acknowledged, however, that the presence of a retained clip, which can be detected at 
time of MRI, may limit the diagnostic accuracy of the scan.  
Video Capsule Endoscopic Recording Devices (Box 8) 
Video capsule endoscopy (VCE) provides a non-invasive method for visualization of the small 
intestine beyond what can be reached through traditional upper endoscopy or colonoscopy and 
can be used to assess a myriad of small bowel disorders (76). VCE devices are wireless and 
generally consist of a capsule containing one or more video cameras, a video chip, batteries, and 
an electronic circuit to either store or transfer data to an external recorder, either by RF waves or 
electrical current (77). Data regarding VCE devices and MRI safety are scarce. VCE devices are 
considered MR Unsafe (77) because of an unknown risk to the bowel wall due to heat or high 
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forces exerted on the device. Additionally, in patients who underwent MRI with retained VCE, 
no diagnostic information could retrieved from the VCE, possibly due to interaction between the 
VCE transmission of data and MRI (77). Therefore, MRI ideally should be delayed until the 
VCE has passed; however, there are no documented instances of harm in a patient with a 
retained VCE undergoing MRI (77). If MRI cannot be delayed until the VCE has passed and is 
deemed necessary for clinical care, then retrieval prior to MRI is recommended. If the VCE is 
irretrievable, MRI could be considered but it should be acknowledged that the device would 
likely be damaged, VCE data lost, and that the evidence for safety is limited. In cases where 
VCE is chronically retained, it is likely that the VCE is not functional and should not be 
considered an absolute contraindication for MRI (Table 2). Screening for VCE devices can be 
accomplished by a screening questionnaire; however, if there is any doubt, abdominal 
radiography can be performed to confirm passage of a VCE device.  
Intrauterine and Fallopian Tube Closure Devices (Box 9) 
Intrauterine devices (IUDs) are commonly used and are either hormone- or metallic- based. IUDs 
which function by inducing hormonal effects are composed of plastic and do not include any 
metallic, magnetic, or conductive materials. Therefore, hormone-based IUDs are considered MR 
Safe. Comparatively, metallic IUDs are typically made with plastic and are wrapped in either 
copper, gold, or steel and therefore are the focus of this section. Copper is the most commonly 
used metal, with up to 380 mm2 surface area on IUDs. Although there is a paucity of literature 
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addressing the MRI safety of IUDs, primary concerns include heating, dislocation, rotation, and 
perforation of the uterine wall, which may result in bleeding or pelvic inflammatory disease.  
Despite limited studies testing MRI safety of IUDs at 1.5T or 3T, no reports of AEs were found 
for IUDs made with copper or gold (78,79). According to various manufacturers’ 
recommendations, all currently marketed metallic IUDs are MR Conditional up to 3T. Some 
discontinued IUDs, such as the Gyne T 380 (Cilag, Sulzbach, Germany) have not been tested at 
3T but are MR Conditional at 1.5T; however, given its similar composition and shape to current 
copper IUDs it may be considered MR Conditional at 3T (80). However, over a decade has 
passed since its discontinuation and it is unlikely any women still have this IUD in situ (81). 
Notably, the Chinese Ring is a stainless steel IUD ring used in China from 1980-2000 and is 
considered MR Unsafe at any field strength due to its potential for displacement and rotation. If 
present, it should be removed prior to MRI (78). Although the use of this IUD was discontinued 
in 2000, its 5- to 20-year lifespan raises the potential that some women may still have the device 
in situ. Screening for this device in the appropriate population is preferred. If there is any doubt 
about its presence, it can be detected with abdominal radiography due to its distinct circular or 
circular braided appearance. For all other IUDs, no AEs when scanning up to 3T have been 
reported (78,79). Of note, the copper IUDs Mona Lisa NT Cu380 (Mona Lisa N.V., Belgium), 
LevoCept, and VeraCept (Sebla Pharmaceuticals, CA, US) are currently undergoing clinical 
trials for FDA approval (NCT03124160, NCT02882191 and NCT03633799, respectively). No 
MRI safety concerns are expected with the Mona Lisa NT Cu380 when scanning at ≤3T (78). 
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The LevoCept and VeraCept are made of a nitinol wire lead and are not expected to have MRI 
safety concerns.  
Fallopian tube closure devices are permanent female sterilization devices; therefore, although 
some devices have since been discontinued, they will be described here. Adiana (Hologic Inc, 
MA, USA) and Ovabloc/Ovalastic (Urogyn b.v, The Netherlands) are made of non-metallic 
materials and are MR Safe. Essure (Bayer Corporation, PA, USA) is a stainless steel coil 
wrapped within a nickel-titanium alloy outer coil. It is MR Conditional at 1.5T (82) and 3T as 
per the manufacturer IFU. The Filshie Clip (CooperSurgical Inc.), Hulka Clip (R. Wolf Medical 
Instruments Corp., IL, USA) Tubal Ligation devices, and AltaSeal (AltaScience Ltd., Ireland) 
are MR Conditional up to 3T.  
Although not located in the uterus or fallopian tubes, subcutaneous birth control implants are a 
related consideration. The implants currently on the market are not metallic and therefore have 
no MR-related restrictions. 
Bullets, shrapnel and foreign metallic objects (Box 10) 
Bullets and shrapnel are commonly seen in victims of war, gang violence, and domestic 
violence. Foreign metallic objects (FMOs) may result from previous injury or metalwork. The 
prevalence of FMOs is approximately 0.20% in the general population (83).  
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The primary concerns with regards to MRI safety revolve around object composition, as 
ferromagnetic materials have the potential to migrate, rotate, or heat. Nonferromagnetic materials 
may also undergo RF-induced heating. Regardless of composition, shape, size, the presence of 
sharp edges and location of the object should also be considered during risk assessment.  
Several studies have shown that ferromagnetic bullets have the potential to migrate up to 10 cm 
in gelatine structures and show significant rotation at both 1.5T and 3T (84-86). However, nearly 
all non-steel and non-nickel containing bullets showed no migration or rotation in magnetic 
fields up to 7T (84,87,88). Although one study found non-steel bullets could migrate and rotate, 
the authors suggested that this could be due to metallic impurities (89).  
Measures of temperature changes have demonstrated a maximum increase of 1.7°C at 3T 
irrespective of bullet composition, which was not significantly different compared to the 
background temperature rises (88). Therefore, MR-related heating of bullets is not of clinical 
concern, unless the FMOs are >3 cm (90). FMOs outside the RF field are unlikely to heat (75).  
If the composition is not clear, it should be presumed to be ferromagnetic for risk assessment. 
Movement or rotation of FMOs could damage nearby vital structures, particularly spinal cord 
and great vessels. Historically, patients with bullets, shrapnel, or FMOs located inside the spinal 
canal are considered unsafe for MRI, but some studies suggest that 1.5T spinal MRIs in patients 
with non-ferromagnetic bullets or shrapnel lodged nearby the spinal cord may be safely 
performed (85,91,92). Additionally, patients with bullet or shrapnel embedded in bone are safe to 
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be scanned, but there is insufficient evidence that fibrous soft tissue around bullets, shrapnel or 
FMOs can safely limit movement (89). Lastly, the shape of the object, including its orientation 
and margins, should be considered. Spherical objects (i.e., BB bullets and shotgun pellets) lack a 
rotational axis but may demonstrate increased longitudinal movement as a result. Non-spherical 
objects rotate to align with the magnetic field, with increased torque observed in stronger 
magnetic fields (86). Elongated FMOs in particular exhibit increased torque and rotation 
tendencies (93). Movement of objects with jagged or sharp margins or pointed edges could result 
in patient injury.  
When there is suspicion or knowledge of a FMO, thorough screening using patient history and 
previous imaging for risk assessment is recommended. If there is still doubt after screening, 
radiographs can help assess the size and location of the FMO. Safety practices that utilize 
handheld and full body sensors for metallic and ferromagnetic materials have been shown to 
reliably detect FMOs (94). However, caution is advised as it is possible these devices may not be 
able to detect small ferromagnetic fragments adjacent to sensitive organs. 
Intraorbital FMOs 
Intraorbital FMOs have the potential to damage the eye and cause blindness, but prevalence is 
rare (95). The first serious AE was presented by Kelly et al. in 1986, where MRI of a patient with 
a 2x3.5 mm intraorbital FMO resulted in unilateral blindness (96). Subsequent reports on AEs 
have been rare, and have not resulted in serious or permanent harm (97-100). One study reported 
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that 2 patients with small (≤0.5mm) intraorbital ferromagnetic FMOs did not experience any 
clinical consequence when scanned at 1.0T (101), but due to the limited number of human 
studies the authors suggested that a thorough screening be performed when there is suspicion of 
intraorbital FMOs. Patients should be questioned about known intraorbital FMOs for which 
medical attention was sought. In such circumstances, existing imaging (e.g., head CT) or if 
necessary, 2-view x-ray orbit films (5) or low dose orbit CT can be used for confirmation (Table 
2). However, CT can detect very small metallic fragments not visible on plain radiographs that 
do not have enough mass to be of clinical significance and therefore the CT should be interpreted 
with caution regarding MRI safety. 
Limitations 
The Delphi method is an iterative process that utilizes repeated rounds and is particularly 
effective for establishing agreement in areas where it did not previously, or necessarily, exist 
(102), as in MRI safety. Although we were able to achieve 100% consensus on our 
recommendations, the results of this study were based on a limited number of experts and may 
not be representative of all MRI safety professionals. Furthermore, limiting our questionnaires to 
dichotomous answers may have forced authors to generalize their recommendations to achieve 
100% consensus. However, the use of a third-party facilitator to generate semi-structured 
teleconferences where discussions on the recommendations could be held should have limited 
this while also reducing peer pressure to concur with individuals.  




New devices are continually introduced that pose ongoing challenges for MR professionals who 
need to ensure device compatibility prior to MRI. This review presented a summary of the MRI 
safety concerns for 10 categories of devices, and literature-based recommendations derived using 
Delphi-inspired measures. These recommendations achieved 100% agreement from a panel of 10 
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Table 1 – MRI safety terminology used in this review, adapted from FDA definitions (96).  
Terminology Definition 
MR Safe 
These items, composed of electrically nonconductive, non-
metallic, and nonmagnetic materials (as per ASTM International 
guidelines), pose no safety hazards in the MR environment. They 
may be placed anywhere in the MR environment. Patients with 
MR Safe devices have no scanning restrictions.  
MR Conditional 
Items that do not pose known hazards when scanned under the 
specific conditions provided in the labelling or product manuals. 
Patients should not be scanned unless the device can be identified 
and all specific conditions are met. Conditions will vary between 
devices and may differ between internal and external parts of the 
same device. Conditions and eligibility may also vary by 
regulatory body. 
 
If the device is labelled as MR Conditional, the MRI safety 
labelling should be matched with the MRI system for: 
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• Static field strength 
• Maximum spatial field gradient 
• dB/dt limitations (usually only applicable to active 
implants) 
• Specific Absorption Rate (SAR) limits 
• Anatomic location of isocenter 
• Scan duration 
• Any other conditions needed for safe use of the device, for 
example restrictions on the types of coils that may be used, 
or device settings 
 
Labels will often include expected temperature increases and 




These items should not enter the screened patient holding area or 
scanner room. Patients with implanted MR Unsafe devices in 
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general should not be scanned (see details in text). 
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Table 2. Recommendations of the panel based on literature review and evidence. All 








Spinal Cord Stimulators with implanted pulse generators and Peripheral Nerve 
Stimulators  
Currently marketed spinal cord stimulators use epidural leads. If 
the leads are displaced to the subdural or intrathecal space, MRI 
could result in spinal cord injury or stimulation. 
Agree 3 
Trial systems and all external components of spinal cord 
stimulators are MR Unsafe and should be removed prior to MRI. 
Agree 2 
Regarding vagus nerve stimulators, except for C7-T8 or C7-L3 
levels (depending on the model) which should remain outside the 
isocenter of the field, MRI of all other body parts is conditional 
at 1.5T and 3T. 
Agree 1 
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In patients with sacral nerve stimulators, brain or spine MRI at 
1.5T is not an absolute contraindication. 
Agree 2 
Cochlear Implants 
With regards to screening, although currently marketed cochlear 
implants are MR Conditional, some of the older ones are MR 
Unsafe. 
Agree 1 
All currently marketed MR Conditional cochlear implants except 
the SYNCHRONY system need removal of the internal magnet 
if a 3T scan is needed. 
Agree 1 
All currently marketed MR Conditional cochlear implants except 
SYNCHRONY system need some variation of head wrapping 
without removal of the internal magnet at 1.5T. 
Agree 1 
The SYNCHRONY cochlear implant is MR Conditional for both 
1.5T and 3T and does not need head wrapping or internal magnet 
removal. 
Agree 1 
Removal of the internal magnet of cochlear implants can 
improve image quality and visualization of immediately adjacent 
Agree 2 
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structures (i.e., ipsilateral internal auditory canal). 
Scleral Buckles and Retinal Tacks 
With regards to MRI safety, screening for scleral buckles is not 
necessary. 
Agree 2 
With regards to MRI safety, screening for retinal tacks, including 
model and manufacturer should be sought as some retinal tacks 
are not safe to scan. 
Agree 2 
Coronary and carotid stents 
With regards to MRI safety, all non-ferromagnetic coronary 
and/or carotid stents can be scanned at 1.5T and 3T. 
Agree 1 
With regards to MRI safety, scanning a ferromagnetic coronary, 
carotid or extremity stent ≤6 weeks after insertion is NOT an 
absolute contraindication provided whole body averaged SAR 
≤2 W/kg and each sequence is 15 minutes maximum. 
Agree 1 
Legacy Pacemakers, Retained Epicardial and Abandoned Intracardiac Leads 
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With regards to MRI safety in patients with temporary 
transvenous pacing wires, screening (by visual confirmation, 
questionnaire, review of surgical reports and/or chest radiograph) 
is recommended. 
Agree 2 
Regarding patients with temporary transvenous pacing wires, 
MRI is unsafe. 
Agree 1 
Regarding retained temporary epicardial pacing wires cut at the 
skin, screening (by questionnaire, review of surgical reports 
and/or chest radiograph if required) is NOT recommended for 
adults who have undergone cardiac surgery. 
Agree 3 
Regarding performing whole body MRI in patients with 
confirmed retained temporary epicardial pacing wires cut at the 
skin, MRI can be performed at 1.5T or 3T. 
Agree 1 
In the immediate post-cardiac surgery period, MRI for patients 
with temporary epicardial pacing wires connected to a fully 
functioning generator, MRI at 1.5T or 3T is unsafe. 
Agree 1 
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Regarding MRI safety for patients with abandoned intracardiac 
and epicardial leads, screening (by questionnaire, review of 
surgical reports and chest radiograph) is required for all patients 
who have undergone implantation of a pacing or defibrillating 
device for electrical stimulation of the heart. 
Agree 1 
Previous guidelines and consensus documents state that 
abandoned intracardiac and epicardial leads are MR Unsafe; 
however, studies show that they may be considered MR 
Conditional at 1.5T.  
Agree 1 
MRI may be performed in a patient with a confirmed abandoned 
permanent intracardiac or abandoned permanent epicardial 
pacemaker lead at 1.5T under controlled conditions using the 
same safety protocols as for patients with leads attached to 
generators. 
Agree 2 
Regarding initial screening in patients with non-conditional 
(legacy) implanted pacemakers or implantable cardioverter 
defibrillators, a radiologist or health care provider should 
determine if MRI would provide useful information to impact 
management and assess alternate modalities that might provide 
Agree 2 
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the same information prior to approving the study. 
The presence of abandoned or fractured intracardiac leads is not 
an absolute contraindication to MRI at 1.5T. 
Agree 2 
Electrophysiology personnel do not have to be present 
throughout the entire scan in patients with legacy devices. 
Electrophysiology personnel are needed after the scan is 
completed. 
Agree 2 
In patients with MR Conditional cardiac implantable electronic 
devices, studies not performed according to the anatomic or SAR 
limitations of the conditions of approval should be undertaken 
using the procedures used for patients with legacy devices. 
Agree 1 
A follow-up interrogation at 30 days is necessary after MRI of a 
patient with a legacy device. 
Disagree 2 
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Currently there is not enough literature evidence to support that 
scanning legacy cardiac implantable electronic devices poses the 
same risks as scanning MR Conditional cardiac implantable 
electronic devices. 
Agree 3 
Endoscopic Hemostatic Clips 
Regarding endoscopic hemostatic clips, screening (by 
questionnaire, review of endoscopy reports and/or abdominal 
radiograph) is suggested for all patients who have undergone 
endoscopy within 2 weeks, unless endoscopy was performed at a 
centre known to use only MR Conditional endoscopic hemostatic 
clips. 
Agree 2 
Regarding endoscopic hemostatic clips, screening (by 
questionnaire, review of endoscopy reports and/or abdominal 
radiograph) is not necessary if endoscopy was performed >2 
weeks before date of MRI. 
Agree 2 
Regarding performing MRI in a patient with a confirmed 
retained MR Unsafe endoscopic hemostatic clip, MRI can be 
considered at 1.5T if MRI is medically indicated, cannot be 
Agree 1 
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delayed, and the risk of potential complication from possible clip 
detachment is considered low. 
Video Capsule Endoscopy Devices 
Regarding performing MRI in a patient with a confirmed 
retained video capsule endoscopy device, MRI should be 
delayed until the device is passed, although MRI is not an 
absolute contraindication. 
Agree 1 
Intrauterine and Fallopian Tube Closure Devices 
With respect to modern intrauterine devices, MRI can be 
performed safely at 3T, with the exception of Chinese ring, 
which is MR Unsafe.  
Agree 2 
With respect to modern fallopian tube closure devices, MRI can 
be performed safely up to 3T. 
Agree 1 
Bullets, shrapnel and foreign metallic objects 
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If there is suspicion for intraorbital foreign metallic objects, 
screening with plain radiographs, low dose orbit CT, and/or 
review of recently obtained head CT is necessary. 
Agree 2 
Metallic objects embedded in vertebral bodies are not 
contraindications to MRI at 1.5T and 3T irrespective of their 
composition. 
Agree 1 
MRI in patients with intra-spinal bullet/shrapnel is not an 
absolute contraindication. For example, in patients with spinal 
cord injury and complete lack of motor and sensory function 
below the level of injury, MRI can be considered if necessary to 
rule out infection. 
Agree 1 
Abbreviations: MRI, magnetic resonance imaging; CT = computed tomography; VCE = video 
capsule endoscopy; SAR = specific absorption rate  
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Box 1. Summary of safety concerns and key recommendations for epidural and peripheral nerve 
catheters. 
Primary concerns are displacement and heating. 
Key Recommendations 
• Screening is recommended and manufacturer guidelines should be followed in 
accordance to the model. 
• Older devices contain stainless steel showed limited deflection and rotation under 3T. 
The modern ones do not contain stainless steel. Some models may be safe to leave in 
place at 1.5T or 3T.  
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Box 2. Summary of safety concerns and key recommendations for spinal cord and peripheral 
nerve stimulators. 
Primary concerns are heating, displacement, and unintentional stimulation and/or device 
alterations. 
Key Recommendations 
• Screening is recommended, and manufacturer guidelines should be followed for the 
specific model. 
o Currently marketed spinal cord stimulators utilize epidural leads and are MR 
Conditional at 1.5T. Trial systems and all external components of spinal cord 
stimulators are MR Unsafe. 
o Regarding vagus nerve stimulators, except for C7-T8 or C7-L3 levels 
(depending on the model), MRI of all other body parts is conditional at 1.5T 
and 3T. 
o For the LivaNova and Cyberonics (now part of LivaNova) vagus nerve 
stimulators, brain or spine MRI at 1.5T is not an absolute contraindication. 
o Within North America, the InterStim sacral nerve stimulator is MR Conditional 
for brain MRI at 1.5T only. Outside North America there are sacral nerve 
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stimulator systems that are MR Conditional at 1.5T and 3T. 
• With the exception of peripheral nerve stimulators, MRI usually should be avoided in 
patients with abandoned devices or components; or broken, non-functional, or 
dislocated leads as per manufacturer guidelines, and due to lack of MRI safety data. If 
MRI is necessary risk-benefit assessment is needed on a case-by-case basis. 
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Box 3. Summary of safety concerns and key recommendations for cochlear and auditory 
brainstem implants. 
Primary concerns are dislocation of internal magnet. Less commonly demagnetization or 
reversal of the magnet may occur.  
Key Recommendations 
• Recommendations apply to both cochlear and auditory brainstem implants. 
• Screening is recommended and the manufacturer guidelines should be followed for the 
specific model. Some of the older cochlear implant models are MR Unsafe. 
• Except the SYNCHRONY system, all currently marketed cochlear implants require 
some variation of a head wrap when scanned with the internal magnet; additionally, the 
internal magnet needs to be removed for 3T MRI. 
• The SYNCHRONY cochlear implant is MR Conditional for both 1.5T and 3T and does 
not need head wrapping or internal magnet removal. 
• Magnet dislodgement can be confirmed with Stenvers-view radiographs.  
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Box 4. Summary of safety concerns and key recommendations for retinal detachment devices. 
There are no concerns with regards to scleral buckles. The primary concern with some retinal 
tacks is dislodgement.  
Key Recommendations 
• Screening for scleral buckle is not necessary. 
• Presence, model and manufacturer of retinal tacks should be sought as some retinal 
tacks are not safe to scan. 
• Retinal tacks used to secure components of the retinal prosthesis system, Argus II, are 
MR Conditional at 1.5T and 3T. 
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Box 5. Summary of safety concerns and key recommendations for coronary and carotid stents. 
Primary concerns are displacement. No studies have found concern with heating.  
Key recommendations 
• The date of stent placement and device manufacturer should be ascertained. 
• Patients with unknown model coronary or carotid stents can be scanned with whole-
body-averaged SAR ≤2 W/kg and maximum 15 minutes per sequence. MR can be 
formed in patients with weakly ferromagnetic coronary and carotid stents at 1.5T or 3T 
six weeks after implantation. Scanning these patients without a 6-week delay can be 
considered on a case-by-case basis. 
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Box 6. Summary of safety concerns and key recommendations for legacy pacemakers, retained 
epicardial pacer wires, and abandoned intracardiac leads 
Primary concerns are change in the setting of pacemaker system and inappropriate pacing and 
heating and movement of the leads. 
Key Recommendations 
• In patients with retained temporary epicardial wires cut at the skin, no screening is 
necessary and whole-body MRI can be performed at 1.5T or 3T.  
• With regards to MRI safety in patients with temporary transvenous pacing wires, 
screening is recommended as MRI is unsafe. 
• Previous guidelines and consensus documents state that abandoned intracardiac and 
epicardial leads are MR Unsafe; however, studies show that they may be considered 
MR Conditional at 1.5T, SAR ≤1.5T, and using the same safety protocols as patients 
with leads attached to generators. 
• In patients with MR Conditional cardiac implantable electronic devices, the procedures 
used for patients with legacy devices should be used when performing scans outside 
the prescribed SAR and anatomic limitations. 
• When scanning patients with legacy devices, electrophysiology personnel are only 
This article is protected by copyright. All rights reserved.
70 
 
needed after the scan is completed but they should be on-call. They do not need to be 
present during the scan and a follow-up at 30 days is not necessary.  
 
Box 7. Summary of safety concerns and key recommendations for endoscopic hemostatic clips. 
Primary safety concerns are mostly theoretical and concern heating. 
Key Recommendations  
• Screening for endoscopic hemostatic clips is suggested for all patients who have 
undergone endoscopy within 2 weeks, unless endoscopy was performed at a center 
known to use only MR Conditional endoscopic hemostatic clips. It is not necessary if 
endoscopy was performed >2 weeks before MRI. 
• MRI can be considered at 1.5T in patients with retained MR Unsafe endoscopic 
hemostatic clips if MRI is medically indicated, cannot be delayed, and the risk of 
potential complication from possible clip detachment is considered low. 
• The presence of retained endoscopic clips can be confirmed by radiography.  
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Box 8. Summary of safety concerns and key recommendations for video capsule endoscopic 
recording devices. 
Primary safety concerns are mostly theoretical and concern heating. 
Key Recommendations  
• MRI should be delayed until video capsule endoscopy device has been passed, 
although MRI is not an absolute contraindication. 
• The presence of video capsule endoscopic recording devices can be confirmed by 
radiography. 
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Box 9. Summary of safety concerns and key recommendations for Intrauterine and Fallopian 
Tube Closure Devices. 
Primary concerns are dislocation, rotation, and heating of the devices as well as perforation of 
female reproductive structures. 
Key Recommendations 
• Hormone-based intrauterine devices (IUDs) are MR Safe. 
• All currently marketed metallic IUDs are MR Conditional up to 3T.  
• The Chinese Ring is MR Unsafe and can be detected with abdominal radiography due 
to its distinct circular or circular braided appearance. 
• MRI can be performed safely up to 3T for patients with fallopian tube closure devices. 
• Subcutaneous birth control implants are MR Safe. 
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Box 10. Summary of safety concerns and key recommendations for metallic foreign objects 
(FMOs).  
Primary concerns are displacement and rotation. Temperature increases are only a concern 
when FMOs >3 cm.  
Key Recommendations 
• When the composition is unknown, it should always be considered ferromagnetic 
during risk assessment. 
• The location and shape of FMO can be assessed via x-ray prior to MR scan if not 
known.  
• FMOs embedded in vertebral bodies are not contraindications to MRI at 1.5T and 3T 
irrespective of their composition. There is insufficient data to comment about the 
safety of FMOs embedded in soft tissue, therefore patients with these should be 
considered on a case-by-case basis. 
• If there is suspicion for intraorbital FMOs, screening with plain radiographs, low dose 
orbit CT, and/or review of recently obtained head CT is necessary. 
 
  




Figure 1. Overview of the methodology employed. 
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